-5%
Ondansetron: A potent, highly selective 5HT3 receptor antagonist used to control nausea and vomiting.
Chemotherapy-Induced Nausea and Vomiting (CINV)
Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of cancer treatment. It can be severe and distressing, significantly affecting the patient’s quality of life and treatment compliance. Ondansetron, a 5HT3 receptor antagonist, is used to treat nausea and vomiting caused by chemotherapy. It works by blocking serotonin, a natural substance that causes nausea and vomiting.
Postoperative Nausea and Vomiting (PONV)
Postoperative nausea and vomiting (PONV) occur immediately after surgery and can continue for a day or two. This condition can be triggered by medications like anesthetics used during surgery. Ondansetron is effective in treating PONV by blocking the action of serotonin in the brain, thereby reducing nausea and vomiting.
Radiation-Induced Nausea and Vomiting (RINV)
Radiation-induced nausea and vomiting (RINV) is a common side effect for cancer patients undergoing radiotherapy. Patients may feel sick during or for a short time after radiotherapy treatment. Ondansetron is used to manage RINV by preventing the action of serotonin, thus alleviating nausea and vomiting during radiotherapy sessions.
